Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, August 2002, p. 2716-2719, Vol. 46, No. 8
0066-4804/02/$04.00+0 DOI: 10.1128/AAC.46.8.2716-2719.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Infectious Diseases Section,1 Research Service, VA Greater Los Angeles Healthcare System, West Los Angeles Division, Los Angeles, California 90073,4 Departments of Medicine,2 Microbiology, Immunology and Molecular Genetics, UCLA School of Medicine, Los Angeles, California 900243
Received 25 June 2001/ Returned for modification 29 November 2001/ Accepted 17 April 2002
ABT-773 was tested against 317 fastidious isolates; it inhibited 99% of organisms at a concentration of 4.0 µg/ml. With ampicillin-sulbactam and levofloxacin, only 2 and 6% of these strains, respectively, were resistant at the breakpoint. With clindamycin, penicillin G, and metronidazole, 22, 26, and 58% of the strains, respectively, were resistant.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»